Glimnac MP 1mg/500mg/15mg Tablet SR
Marketer
Spencure Biotech Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimnac MP 1mg/500mg/15mg Tablet SR
Glimnac MP SR tablets (1mg/500mg/15mg) combine medications to manage blood glucose in adults with type 2 diabetes. This treatment complements diet and exercise to enhance blood sugar regulation by improving insulin effectiveness. Follow your physician's prescribed dosage and duration; take with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. Excessive dosage can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia is possible with concurrent use of other diabetes medications, alcohol, or skipped meals; monitor blood glucose frequently. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor before use if you have kidney, liver, or heart conditions, or if you are pregnant or breastfeeding. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption to reduce the risk of side effects.
Primary Ingredients of Glimnac MP 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimnac MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimnac MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimnac MP 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Glimnac MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimnac MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimnac MP 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Consume this medicine with a meal.
How Glimnac MP 1mg/500mg/15mg Tablet SR works:
Glimnac MP 1mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood glucose management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimnac MP 1mg/500mg/15mg SR tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimnac MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimnac MP tablets (1mg/500mg/15mg) are likely not safe for use while breastfeeding. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimnac MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For individuals with severe kidney disease, Glimnac MP 1mg/500mg/15mg SR tablets are contraindicated. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimnac MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Glimnac MP 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimnac MP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glimnac MP 1mg/500mg/15mg SR Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimnac MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently